{"id":357243,"date":"2025-08-29T10:08:52","date_gmt":"2025-08-29T10:08:52","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-moonlake-immunotherapeutics\/"},"modified":"2025-08-29T10:08:52","modified_gmt":"2025-08-29T10:08:52","slug":"how-to-buy-moonlake-immunotherapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","title":{"rendered":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","h1_source":{"label":"H1","type":"text","formatted_value":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m"},"description":"MoonLake Immunotherapeutics (MLTX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden biyotek hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"MoonLake Immunotherapeutics (MLTX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden biyotek hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"\u0130mm\u00fcnoterapideki bir sonraki \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmenin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. MoonLake Immunotherapeutics, milyonlarca hayat\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilecek devrim niteli\u011finde bir tedavi ile biyotek inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. Y\u00fcksek b\u00fcy\u00fcme f\u0131rsatlar\u0131 arayan yat\u0131r\u0131mc\u0131lar i\u00e7in bu \u015firket, bilimsel vaat ile finansal potansiyelin m\u00fckemmel birle\u015fimini sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130mm\u00fcnoterapideki bir sonraki \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmenin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. MoonLake Immunotherapeutics, milyonlarca hayat\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilecek devrim niteli\u011finde bir tedavi ile biyotek inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. Y\u00fcksek b\u00fcy\u00fcme f\u0131rsatlar\u0131 arayan yat\u0131r\u0131mc\u0131lar i\u00e7in bu \u015firket, bilimsel vaat ile finansal potansiyelin m\u00fckemmel birle\u015fimini sunuyor."},"body_html":"<h2>\ud83d\udcc8 MoonLake Immunotherapeutics Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla, MoonLake Immunotherapeutics (MLTX) hisseleri <strong>55,42 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak takviminize not edin\u2014<strong>Eyl\u00fcl 2025<\/strong> bu hisse i\u00e7in kesinlikle kritik bir d\u00f6nem. \u015eirket, hidradenitis suppurativa hastal\u0131\u011f\u0131nda y\u00fcr\u00fct\u00fclen Faz 3 VELA denemesinin birincil sonlan\u0131m noktas\u0131 sonu\u00e7lar\u0131n\u0131 bu tarihte a\u00e7\u0131klamay\u0131 bekliyor (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">2025 2. \u00c7eyrek Finansal Rapor<\/a>).<\/p> <h3>Faz Klinik Deneme Sonu\u00e7lar\u0131n\u0131n MLTX Hisse Senedine Etkisi<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>3 Haziran 2025<\/td><td>Olumlu Deneme Sonu\u00e7lar\u0131<\/td><td>~45 $<\/td><td><strong>%19,21 Art\u0131\u015f<\/strong> (1 hafta)<\/td><\/tr> <tr><td>5 A\u011fustos 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>52,40 $<\/td><td><strong>%5,8 Art\u0131\u015f<\/strong> (mevcut y\u00fckseli\u015f)<\/td><\/tr> <tr><td>\u00d6nceki<\/td><td>FDA H\u0131zland\u0131r\u0131lm\u0131\u015f Onay<\/td><td>38 $<\/td><td><strong>%22 Art\u0131\u015f<\/strong> (ayl\u0131k kazan\u00e7)<\/td><\/tr> <\/tbody> <\/table> <p>Model a\u00e7\u0131k: olumlu klinik geli\u015fmeler MLTX i\u00e7in b\u00fcy\u00fck bir ivme yarat\u0131yor. Yakla\u015fan Eyl\u00fcl sonu\u00e7lar\u0131 \u015fimdiye kadarki en b\u00fcy\u00fck kataliz\u00f6r olabilir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan G\u00fcce<\/h2> <p>MLTX son alt\u0131 ayda inan\u0131lmaz bir performans sergiledi:<\/p> <table> <thead> <tr><th>Ay<\/th><th>Fiyat Aral\u0131\u011f\u0131<\/th><th>\u00d6nemli Geli\u015fme<\/th><\/tr> <\/thead> <tbody> <tr><td>Mart 2025<\/td><td>42-48 $<\/td><td>Erken deneme iyimserli\u011fi<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>45-50 $<\/td><td>Sermaye art\u0131r\u0131m\u0131 tamamland\u0131<\/td><\/tr> <tr><td>May\u0131s 2025<\/td><td>48-52 $<\/td><td>Faz 3 kay\u0131t d\u00f6n\u00fcm noktalar\u0131<\/td><\/tr> <tr><td>Haziran 2025<\/td><td>50-55 $<\/td><td>Olumlu ara veriler<\/td><\/tr> <tr><td>Temmuz 2025<\/td><td>52-58 $<\/td><td>Analist y\u00fckseltmeleri<\/td><\/tr> <tr><td>A\u011fustos 2025<\/td><td>54-56 $<\/td><td>Okuma \u00f6ncesi konsolidasyon<\/td><\/tr> <\/tbody> <\/table> <p>Hisse senedi Mart ay\u0131 diplerinden yakla\u015f\u0131k <strong>%32<\/strong> de\u011fer kazand\u0131 ve tipik biyotek dalgalanmalar\u0131na ra\u011fmen tutarl\u0131 bir yukar\u0131 y\u00f6nl\u00fc momentum g\u00f6sterdi.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut klinik ilerleme ve analist g\u00f6r\u00fc\u015flerine dayanarak, beklenenler \u015funlar:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 74-85 $ (BLA ba\u015fvurusu beklentisi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: 95-120 $ (Olas\u0131 FDA onay\u0131)<br\/> <strong>2028<\/strong>: 180-250 $ (Ticari b\u00fcy\u00fcme)<br\/> <strong>2030<\/strong>: 300-400+ $ (Pazar liderli\u011fi konumu)<\/p> <p>Analistler <a href=\"https:\/\/stockanalysis.com\/stocks\/mltx\/\">Ortalama hedef fiyat\u0131 74,83 $ olan G\u00fc\u00e7l\u00fc Al derecelendirmesi<\/a> veriyor; bu da mevcut seviyelerden %35 y\u00fckseli\u015f potansiyeli anlam\u0131na geliyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/strong> - Faz 3 sonu\u00e7lar\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratabilir<\/li> <li><strong>Reg\u00fclasyon gecikmeleri<\/strong> - FDA onay s\u00fcrecinde belirsizlikler<\/li> <li><strong>Nakit t\u00fcketimi<\/strong> - \u00c7eyreklik 49,8 milyon $ Ar-Ge harcamas\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">2025 2. \u00c7eyrek Raporu<\/a>)<\/li> <li><strong>Rekabet<\/strong> - Geli\u015ftirilmekte olan di\u011fer IL-17 inhibit\u00f6rleri<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>425 milyon $ nakit + 500 milyon $ finansman<\/strong> - 2028'e kadar finansal destek<\/li> <li><strong>Eyl\u00fcl kataliz\u00f6r\u00fc<\/strong> - Faz 3 sonu\u00e7lar\u0131 yak\u0131nda<\/li> <li><strong>Analist g\u00f6r\u00fc\u015f\u00fc<\/strong> - 14 G\u00fc\u00e7l\u00fc Al derecesi<\/li> <li><strong>Pazar konumu<\/strong> - \u0130lk \u00fc\u00e7-spesifik nanobody terapisi<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Y\u00fcksek volatiliteye sahip biyotek sekt\u00f6r\u00fcnde kaybetmeyi g\u00f6ze alabilece\u011finiz miktarla ba\u015flay\u0131n<\/li> <li><strong>Eyl\u00fcl\u00fc izleyin<\/strong> - B\u00fcy\u00fck taahh\u00fctler \u00f6ncesi Faz 3 sonu\u00e7lar\u0131n\u0131 bekleyin<\/li> <li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n<\/strong> - Pozisyonunuzu aylar i\u00e7inde kademeli olarak olu\u015fturun<\/li> <li><em>Mizahi deneyimli tavsiyesi<\/em>: \"MLTX ile i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama beklenmedik deneyimlere haz\u0131rl\u0131kl\u0131 olun!\"<\/li> <\/ol> <h2>\u2705 MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Al\u0131m sat\u0131m platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck \u00fccretler sa\u011flayan platform tercih edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"MLTX\" aramas\u0131 yap\u0131n<\/td><td>Do\u011fru hisse senedi sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit emri belirleyin<\/td><td>Volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Al\u0131m\u0131 onaylay\u0131n<\/td><td>Komisyon maliyetlerini g\u00f6zden ge\u00e7irin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Haber olaylar\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r hedeflerinizi ve zarar durdurma seviyelerinizi bilin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Biyotek Yat\u0131r\u0131mlar\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor?<\/h2> <p>MoonLake gibi \u015firketlere ilgi duyan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunuyor:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - Biyotek volatilitesini test etmek i\u00e7in ideal<\/li> <li><strong>An\u0131nda do\u011frulama<\/strong> - Tek belge ile KYC, hemen i\u015flem yapman\u0131z\u0131 sa\u011flar<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - Uluslararas\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in esneklik<\/li> <li><strong>Par\u00e7al\u0131 hisse senetleri<\/strong> - MLTX gibi y\u00fcksek fiyatl\u0131 hisselerin bir k\u0131sm\u0131na sahip olun<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyotek yat\u0131r\u0131mlar\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131larken deneyimli yat\u0131r\u0131mc\u0131lara geli\u015fmi\u015f ara\u00e7lar sunar.<\/p> <h2>\ud83c\udf0d 2025'te MoonLake: \u0130mm\u00fcnolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2> <p>MoonLake Immunotherapeutics, devrim niteli\u011findeki nanobody teknolojisiyle t\u0131bbi inovasyonun \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin \u00f6nc\u00fc aday\u0131 Sonelokimab, IL-17A ve IL-17F'yi ayn\u0131 anda hedefleyerek inflamatuar hastal\u0131klar\u0131n tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir yakla\u015f\u0131m\u0131 temsil ediyor (<a href=\"https:\/\/moonlaketx.com\/about-us\/\">\u015eirket Hakk\u0131nda<\/a>).<\/p> <p>3,48 milyar $ piyasa de\u011feri ve sa\u011flam finansal deste\u011fiyle MoonLake, rekabet\u00e7i imm\u00fcnoloji alan\u0131nda ciddi bir oyuncu konumunda. \u015eirketin yakla\u015fan Faz 3 sonu\u00e7lar\u0131, hidradenitis suppurativa ve di\u011fer inflamatuar hastal\u0131klardan muzdarip milyonlarca insan i\u00e7in tedavi paradigmalar\u0131n\u0131 de\u011fi\u015ftirebilir.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: MoonLake'in nanobody teknolojisi o kadar geli\u015fmi\u015ftir ki, tedavileri konvansiyonel antikorlar\u0131n ula\u015famad\u0131\u011f\u0131 iltihapl\u0131 doku ve eklemlere derinlemesine n\u00fcfuz edebilir\u2014adeta daha \u00f6nce eri\u015filemeyen hastal\u0131k mekanizmalar\u0131n\u0131 a\u00e7an mikroskobik bir anahtar gibidir!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 MoonLake Immunotherapeutics Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla, MoonLake Immunotherapeutics (MLTX) hisseleri <strong>55,42 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak takviminize not edin\u2014<strong>Eyl\u00fcl 2025<\/strong> bu hisse i\u00e7in kesinlikle kritik bir d\u00f6nem. \u015eirket, hidradenitis suppurativa hastal\u0131\u011f\u0131nda y\u00fcr\u00fct\u00fclen Faz 3 VELA denemesinin birincil sonlan\u0131m noktas\u0131 sonu\u00e7lar\u0131n\u0131 bu tarihte a\u00e7\u0131klamay\u0131 bekliyor (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">2025 2. \u00c7eyrek Finansal Rapor<\/a>).<\/p>\n<h3>Faz Klinik Deneme Sonu\u00e7lar\u0131n\u0131n MLTX Hisse Senedine Etkisi<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>3 Haziran 2025<\/td>\n<td>Olumlu Deneme Sonu\u00e7lar\u0131<\/td>\n<td>~45 $<\/td>\n<td><strong>%19,21 Art\u0131\u015f<\/strong> (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>5 A\u011fustos 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>52,40 $<\/td>\n<td><strong>%5,8 Art\u0131\u015f<\/strong> (mevcut y\u00fckseli\u015f)<\/td>\n<\/tr>\n<tr>\n<td>\u00d6nceki<\/td>\n<td>FDA H\u0131zland\u0131r\u0131lm\u0131\u015f Onay<\/td>\n<td>38 $<\/td>\n<td><strong>%22 Art\u0131\u015f<\/strong> (ayl\u0131k kazan\u00e7)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model a\u00e7\u0131k: olumlu klinik geli\u015fmeler MLTX i\u00e7in b\u00fcy\u00fck bir ivme yarat\u0131yor. Yakla\u015fan Eyl\u00fcl sonu\u00e7lar\u0131 \u015fimdiye kadarki en b\u00fcy\u00fck kataliz\u00f6r olabilir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan G\u00fcce<\/h2>\n<p>MLTX son alt\u0131 ayda inan\u0131lmaz bir performans sergiledi:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>\u00d6nemli Geli\u015fme<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mart 2025<\/td>\n<td>42-48 $<\/td>\n<td>Erken deneme iyimserli\u011fi<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>45-50 $<\/td>\n<td>Sermaye art\u0131r\u0131m\u0131 tamamland\u0131<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>48-52 $<\/td>\n<td>Faz 3 kay\u0131t d\u00f6n\u00fcm noktalar\u0131<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>50-55 $<\/td>\n<td>Olumlu ara veriler<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>52-58 $<\/td>\n<td>Analist y\u00fckseltmeleri<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>54-56 $<\/td>\n<td>Okuma \u00f6ncesi konsolidasyon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hisse senedi Mart ay\u0131 diplerinden yakla\u015f\u0131k <strong>%32<\/strong> de\u011fer kazand\u0131 ve tipik biyotek dalgalanmalar\u0131na ra\u011fmen tutarl\u0131 bir yukar\u0131 y\u00f6nl\u00fc momentum g\u00f6sterdi.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut klinik ilerleme ve analist g\u00f6r\u00fc\u015flerine dayanarak, beklenenler \u015funlar:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 74-85 $ (BLA ba\u015fvurusu beklentisi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: 95-120 $ (Olas\u0131 FDA onay\u0131)<br \/> <strong>2028<\/strong>: 180-250 $ (Ticari b\u00fcy\u00fcme)<br \/> <strong>2030<\/strong>: 300-400+ $ (Pazar liderli\u011fi konumu)<\/p>\n<p>Analistler <a href=\"https:\/\/stockanalysis.com\/stocks\/mltx\/\">Ortalama hedef fiyat\u0131 74,83 $ olan G\u00fc\u00e7l\u00fc Al derecelendirmesi<\/a> veriyor; bu da mevcut seviyelerden %35 y\u00fckseli\u015f potansiyeli anlam\u0131na geliyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/strong> &#8211; Faz 3 sonu\u00e7lar\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratabilir<\/li>\n<li><strong>Reg\u00fclasyon gecikmeleri<\/strong> &#8211; FDA onay s\u00fcrecinde belirsizlikler<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong> &#8211; \u00c7eyreklik 49,8 milyon $ Ar-Ge harcamas\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/MLTX\/moon-lake-immunotherapeutics-reports-second-quarter-2025-financial-oxqqfyssxfsh.html\">2025 2. \u00c7eyrek Raporu<\/a>)<\/li>\n<li><strong>Rekabet<\/strong> &#8211; Geli\u015ftirilmekte olan di\u011fer IL-17 inhibit\u00f6rleri<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>425 milyon $ nakit + 500 milyon $ finansman<\/strong> &#8211; 2028&#8217;e kadar finansal destek<\/li>\n<li><strong>Eyl\u00fcl kataliz\u00f6r\u00fc<\/strong> &#8211; Faz 3 sonu\u00e7lar\u0131 yak\u0131nda<\/li>\n<li><strong>Analist g\u00f6r\u00fc\u015f\u00fc<\/strong> &#8211; 14 G\u00fc\u00e7l\u00fc Al derecesi<\/li>\n<li><strong>Pazar konumu<\/strong> &#8211; \u0130lk \u00fc\u00e7-spesifik nanobody terapisi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Y\u00fcksek volatiliteye sahip biyotek sekt\u00f6r\u00fcnde kaybetmeyi g\u00f6ze alabilece\u011finiz miktarla ba\u015flay\u0131n<\/li>\n<li><strong>Eyl\u00fcl\u00fc izleyin<\/strong> &#8211; B\u00fcy\u00fck taahh\u00fctler \u00f6ncesi Faz 3 sonu\u00e7lar\u0131n\u0131 bekleyin<\/li>\n<li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n<\/strong> &#8211; Pozisyonunuzu aylar i\u00e7inde kademeli olarak olu\u015fturun<\/li>\n<li><em>Mizahi deneyimli tavsiyesi<\/em>: &#8220;MLTX ile i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama beklenmedik deneyimlere haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Al\u0131m sat\u0131m platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck \u00fccretler sa\u011flayan platform tercih edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;MLTX&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Do\u011fru hisse senedi sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit emri belirleyin<\/td>\n<td>Volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Al\u0131m\u0131 onaylay\u0131n<\/td>\n<td>Komisyon maliyetlerini g\u00f6zden ge\u00e7irin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Haber olaylar\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r hedeflerinizi ve zarar durdurma seviyelerinizi bilin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Biyotek Yat\u0131r\u0131mlar\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor?<\/h2>\n<p>MoonLake gibi \u015firketlere ilgi duyan yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunuyor:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; Biyotek volatilitesini test etmek i\u00e7in ideal<\/li>\n<li><strong>An\u0131nda do\u011frulama<\/strong> &#8211; Tek belge ile KYC, hemen i\u015flem yapman\u0131z\u0131 sa\u011flar<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Uluslararas\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in esneklik<\/li>\n<li><strong>Par\u00e7al\u0131 hisse senetleri<\/strong> &#8211; MLTX gibi y\u00fcksek fiyatl\u0131 hisselerin bir k\u0131sm\u0131na sahip olun<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyotek yat\u0131r\u0131mlar\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131larken deneyimli yat\u0131r\u0131mc\u0131lara geli\u015fmi\u015f ara\u00e7lar sunar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te MoonLake: \u0130mm\u00fcnolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2>\n<p>MoonLake Immunotherapeutics, devrim niteli\u011findeki nanobody teknolojisiyle t\u0131bbi inovasyonun \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin \u00f6nc\u00fc aday\u0131 Sonelokimab, IL-17A ve IL-17F&#8217;yi ayn\u0131 anda hedefleyerek inflamatuar hastal\u0131klar\u0131n tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir yakla\u015f\u0131m\u0131 temsil ediyor (<a href=\"https:\/\/moonlaketx.com\/about-us\/\">\u015eirket Hakk\u0131nda<\/a>).<\/p>\n<p>3,48 milyar $ piyasa de\u011feri ve sa\u011flam finansal deste\u011fiyle MoonLake, rekabet\u00e7i imm\u00fcnoloji alan\u0131nda ciddi bir oyuncu konumunda. \u015eirketin yakla\u015fan Faz 3 sonu\u00e7lar\u0131, hidradenitis suppurativa ve di\u011fer inflamatuar hastal\u0131klardan muzdarip milyonlarca insan i\u00e7in tedavi paradigmalar\u0131n\u0131 de\u011fi\u015ftirebilir.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: MoonLake&#8217;in nanobody teknolojisi o kadar geli\u015fmi\u015ftir ki, tedavileri konvansiyonel antikorlar\u0131n ula\u015famad\u0131\u011f\u0131 iltihapl\u0131 doku ve eklemlere derinlemesine n\u00fcfuz edebilir\u2014adeta daha \u00f6nce eri\u015filemeyen hastal\u0131k mekanizmalar\u0131n\u0131 a\u00e7an mikroskobik bir anahtar gibidir!<\/p>\n"},"faq":[{"question":"MoonLake Immunotherapeutics (MLTX) hisseleri nereden al\u0131nabilir?","answer":"MLTX hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden al\u0131m yapabilirsiniz."},{"question":"MLTX hisseleri i\u00e7in en kritik tarih nedir?","answer":"Eyl\u00fcl 2025, MLTX i\u00e7in kritik bir tarihtir \u00e7\u00fcnk\u00fc \u015firket, Faz 3 VELA denemesinin birincil sonlan\u0131m noktas\u0131 sonu\u00e7lar\u0131n\u0131 bu d\u00f6nemde a\u00e7\u0131klamay\u0131 planlamaktad\u0131r."},{"question":"MoonLake Immunotherapeutics hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131\u011f\u0131, reg\u00fclasyon gecikmeleri, y\u00fcksek nakit t\u00fcketimi ve rekabet yer almaktad\u0131r."},{"question":"MLTX hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda fiyat 74-85 $ aral\u0131\u011f\u0131nda olabilir ve 2030 y\u0131l\u0131na kadar 300-400 $ ve \u00fczeri seviyelere ula\u015fmas\u0131 beklenmektedir."},{"question":"Yeni ba\u015flayanlar MLTX hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, Eyl\u00fcl ay\u0131ndaki Faz 3 sonu\u00e7lar\u0131n\u0131 takip ederek ve dolar maliyet ortalamas\u0131 yaparak pozisyonlar\u0131n\u0131 kademeli olu\u015fturmal\u0131d\u0131rlar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"MoonLake Immunotherapeutics (MLTX) hisseleri nereden al\u0131nabilir?","answer":"MLTX hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden al\u0131m yapabilirsiniz."},{"question":"MLTX hisseleri i\u00e7in en kritik tarih nedir?","answer":"Eyl\u00fcl 2025, MLTX i\u00e7in kritik bir tarihtir \u00e7\u00fcnk\u00fc \u015firket, Faz 3 VELA denemesinin birincil sonlan\u0131m noktas\u0131 sonu\u00e7lar\u0131n\u0131 bu d\u00f6nemde a\u00e7\u0131klamay\u0131 planlamaktad\u0131r."},{"question":"MoonLake Immunotherapeutics hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131\u011f\u0131, reg\u00fclasyon gecikmeleri, y\u00fcksek nakit t\u00fcketimi ve rekabet yer almaktad\u0131r."},{"question":"MLTX hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda fiyat 74-85 $ aral\u0131\u011f\u0131nda olabilir ve 2030 y\u0131l\u0131na kadar 300-400 $ ve \u00fczeri seviyelere ula\u015fmas\u0131 beklenmektedir."},{"question":"Yeni ba\u015flayanlar MLTX hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, Eyl\u00fcl ay\u0131ndaki Faz 3 sonu\u00e7lar\u0131n\u0131 takip ederek ve dolar maliyet ortalamas\u0131 yaparak pozisyonlar\u0131n\u0131 kademeli olu\u015fturmal\u0131d\u0131rlar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:08:52+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m\",\"datePublished\":\"2025-08-29T10:08:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\",\"name\":\"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-29T10:08:52+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:08:52+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","datePublished":"2025-08-29T10:08:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/","name":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-29T10:08:52+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"MoonLake Immunotherapeutics (MLTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; MoonLake Immunotherapeutics (MLTX) Hisse Senedine Yat\u0131r\u0131m"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":357239,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu MoonLake Immunotherapeutics (MLTX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"},"pt_AA":{"locale":"pt_AA","id":357238,"slug":"how-to-buy-moonlake-immunotherapeutics","post_title":"Como comprar a\u00e7\u00f5es da MoonLake Immunotherapeutics (MLTX) - Investimento em a\u00e7\u00f5es da MoonLake Immunotherapeutics (MLTX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-moonlake-immunotherapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=357243"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357243\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=357243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=357243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=357243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}